Our research within AI does not stop. We have new systems that can generate biological data indistinguishable from real biological data and can now imagine high-quality…
In Conversation
To some extent, we are the poster child for how not to respond with COVID-19
Fundamentally, we need to keep an open mind about learning from existing models, yet should avoid simply copying and pasting what has worked in other countries…
My personal mission is to position Pangenia to be one of the largest molecular diagnostics companies based in Hong Kong, facing the South East Asian market
JLABS @ Shanghai is a no-strings-attached incubator, which means entrepreneurs are free to develop their science while holding on to their intellectual property - providing a…
Affordability is key. We recently launched a specialty pharmacy network for our portfolio. This allows us to bypass wholesalers and retail pharmacies, reducing our costs
Nowadays, there are a substantial number of drugs unavailable in Belgium, but readily available in other European countries. Through parallel imports, we are able to safely…
Looking at the longer term, I believe this COVID-19 crisis will have a positive impact on the diagnostics industry by changing the approach countries take towards…
Sub-Saharan Africa has huge potential, with the population expected to increase by more than one billion by 2050.
When no bridging process can be found, Pfizer donates the medicines to hospitals that request it. Half of Pfizer’s investments are done through donations, as a…
Given our status as a raw materials developer, we see an opportunity to expand our offering during this pandemic. Our agility and ability to re-orientate our…
Hong Kong has a unique profile, with both Chinese and international DNA. From a markets point of view, we have demonstrated that our markets are robust…
